TFFP News and Press, TFF Pharmaceuticals Inc - Ordinary Shares From 12/11/19

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that it will be meeting with investors and commercial par...

TFF Pharmaceuticals (NASDAQ: TFFP ): Q3 GAAP EPS of -$0.70. More news on: TFF Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Company initiates Phase 1 clinical trial of Voriconazole Inhalation Powder, to treat invasive pulmonary aspergillosis (IPA) Successfully completes $24 million initial public offering of common stock TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical comp...